Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 2. Effect of MHY4381 and SAHA on viability and morphology of prostate cancer (DU145, LNCaP, or PC-3) cells. (A) The cells were treated with MHY4381 or SAHA at various concentrations (0.01-10 μM) for 24 h and 48 h. Cell viability was assessed using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and the data represent the mean ± SD of three independent experiments. (B) Morphological changes (cell body shrinkage and reduction of cell number) in the cells were documented by photography after MHY4381 (1 μM) and SAHA (1 μM) treatment for 48 h. Light microscopic images representative of three independent experiments are shown. Scale bar, 100 μm. (C) The effect of MHY4381 or SAHA on prostate cancer single cell proliferation assessed by colony formation assay. Prostate cancer cells were treated with MHY4381 (1 μM) or SAHA (1 μM), and allowed to form colonies in fresh medium for 14 days. (D) Representative histogram showing the plating efficiency percentage in prostate cancer cells. Data are expressed as mean ± SD (n=3). **p<0.01, ***p<0.001 versus control group.
Biomolecules & Therapeutics 2020;28:184~194
© Biomolecules & Therapeutics